Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study

Saved in:
Bibliographic Details
Published in:International Journal of Women's Health
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870387909246320640
collection WordPress RSS
FRELIP Feed Integration
container_title International Journal of Women's Health
description
discipline_display Women's Health
discipline_facet Women's Health
format Online Article
RSS Article
genre Journal Article
id rss_article:101742
institution FRELIP
journal_source_facet International Journal of Women's Health
last_indexed 2026-07-11T03:35:10.476Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study
Women's Health
General
Women's Health
sub_discipline_display General
sub_discipline_facet General
subject_display Women's Health
General
Women's Health
subject_facet Women's Health
General
Women's Health
title Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study
title_alt El síndrome metabólico predice resistencia a la quimioterapia y mal pronóstico en el cáncer de ovario epitelial: Un estudio de cohorte observacional retrospectivo
Le syndrome métabolique prédit la résistance à la chimiothérapie et un mauvais pronostic dans le cancer épithélial de l'ovaire : Une étude de cohorte observationnelle rétrospective
Síndrome Metabólica Prediz Resistência à Quimioterapia e Mau Prognóstico no Câncer de Ovário Epitelial: Um Estudo de Coorte Observacional Retrospectivo
title_auth Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study
title_es_txt El síndrome metabólico predice resistencia a la quimioterapia y mal pronóstico en el cáncer de ovario epitelial: Un estudio de cohorte observacional retrospectivo
title_fr_txt Le syndrome métabolique prédit la résistance à la chimiothérapie et un mauvais pronostic dans le cancer épithélial de l'ovaire : Une étude de cohorte observationnelle rétrospective
title_full Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study
title_fullStr Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study
title_full_unstemmed Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study
title_pt_txt Síndrome Metabólica Prediz Resistência à Quimioterapia e Mau Prognóstico no Câncer de Ovário Epitelial: Um Estudo de Coorte Observacional Retrospectivo
title_short Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study
title_sort metabolic syndrome predicts chemotherapy resistance and poor prognosis in epithelial ovarian cancer: a retrospective observational cohort study
topic Women's Health
General
Women's Health
url https://www.dovepress.com/metabolic-syndrome-predicts-chemotherapy-resistance-and-poor-prognosis-peer-reviewed-fulltext-article-IJWH